A comparison of case-finding strategies in the UK for the management of hip fractures

被引:36
作者
Johansson, H. [2 ]
Kanis, J. A. [3 ]
Oden, A. [2 ]
Compston, J. [4 ,5 ]
McCloskey, E. [1 ,3 ]
机构
[1] No Gen Hosp, Metab Bone Ctr, WHO Collaborating Ctr Metab Bone Dis, Sheffield S5 7AU, S Yorkshire, England
[2] Consulting Statisticians, Gothenburg, Sweden
[3] Univ Sheffield, WHO Collaborating Ctr Metab Bone Dis, Sheffield, S Yorkshire, England
[4] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England
[5] Addenbrookes NHS Trust, Cambridge CB2 2QQ, England
关键词
Fracture; FRAX; Guideline; Number needed to scan; Treatment threshold; UK; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; INTERVENTION THRESHOLDS; OSTEOPOROTIC FRACTURES; PRACTICE GUIDELINES; RISK-ASSESSMENT; PREVENTION; DIAGNOSIS; TRIAL; MEN;
D O I
10.1007/s00198-011-1864-y
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Treatment criteria published by the National Osteoporosis Guideline Group (NOGG) in the UK make more efficient use of bone mineral density (BMD) resources than the previous Royal College of Physicians (RCP) guideline. We compared the effectiveness of the RCP case-finding strategy previously used in the UK and the updated guideline published by NOGG, which incorporates the FRAXA (R) fracture probability tool. Comparisons were made by simulating population samples of 1000 women at ages between 50 and 85 years, using age-specific prevalence of risk factors and UK-derived fracture and mortality rates. Comparators comprised the number identified at high risk, the incidence of hip fracture and the femoral neck BMD in those identified, the number needed to scan to identify a hip fracture, the acquisition cost and the cost per hip fracture averted Compared with the RCP strategy, NOGG identified slightly reduced numbers of women at high risk (average 34.6% vs. 35.7% across all ages), but with lower numbers of scans required at each age. For example, NOGG required only 3.5 scans at the age of 50 years to identify one case of hip fracture, whereas RCP required 13.9. At 75 years, the corresponding numbers were 0.9 and 1.5. Thus, the acquisition costs for identifying a hip fracture case and the total costs (acquisition and treatment) per hip fracture averted were lower. Compared to the RCP strategy, the FRAX-based NOGG strategy uses BMD resources more efficiently with lower acquisition costs and lower costs per hip fracture averted.
引用
收藏
页码:907 / 915
页数:9
相关论文
共 35 条
[1]
[Anonymous], 2008, CLIN GUID PREV TREAT
[2]
[Anonymous], 2008, ASSESSMENT OSTEOPORO
[3]
Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data [J].
Bell, Katy J. L. ;
Hayen, Andrew ;
Macaskill, Petra ;
Irwig, Les ;
Craig, Jonathan C. ;
Ensrud, Kristine ;
Bauer, Douglas C. .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 :1553
[4]
Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial [J].
Black, Dennis M. ;
Schwartz, Ann V. ;
Ensrud, Kristine E. ;
Cauley, Jane A. ;
Levis, Silvina ;
Quandt, Sara A. ;
Satterfield, Suzanne ;
Wallace, Robert B. ;
Bauer, Douglas C. ;
Palermo, Lisa ;
Wehren, Lois E. ;
Lombardi, Antonio ;
Santora, Arthur C. ;
Cummings, Steven R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (24) :2927-2938
[5]
An assessment tool for predicting fracture risk in postmenopausal women [J].
Black, DM ;
Steinbuch, M ;
Palermo, L ;
Dargent-Molina, P ;
Lindsay, R ;
Hoseyni, MS ;
Johnell, O .
OSTEOPOROSIS INTERNATIONAL, 2001, 12 (07) :519-528
[6]
Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care [J].
Cheung, AM ;
Feig, DS ;
Kapral, M ;
Diaz-Granados, N ;
Dodin, S .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 170 (11) :1665-1667
[7]
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK [J].
Compston, J. ;
Cooper, A. ;
Cooper, C. ;
Francis, R. ;
Kanis, J. A. ;
Marsh, D. ;
McCloskey, E. V. ;
Reid, D. M. ;
Selby, P. ;
Wilkins, M. .
MATURITAS, 2009, 62 (02) :105-108
[8]
Monitoring bone mineral density during antiresorptive treatment for osteoporosis [J].
Compston, Juliet .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338
[9]
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - Results from the fracture intervention trial [J].
Cummings, SR ;
Black, DM ;
Thompson, DE ;
Applegate, WB ;
Barrett-Connor, E ;
Musliner, TA ;
Palermo, L ;
Prineas, R ;
Rubin, SM ;
Scott, JC ;
Vogt, T ;
Wallace, R ;
Yates, AJ ;
LaCroix, AZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (24) :2077-2082
[10]
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA [J].
Dawson-Hughes, B. ;
Tosteson, A. N. A. ;
Melton, L. J., III ;
Baim, S. ;
Favus, M. J. ;
Khosla, S. ;
Lindsay, R. L. .
OSTEOPOROSIS INTERNATIONAL, 2008, 19 (04) :449-458